A Phase II Study of Temsirolimus and Erlotinib in Patients With Recurrent and/or Metastatic, Platinum-Refractory Head and Neck Squamous Cell Carcinoma
Oral Oncology - United Kingdom
doi 10.1016/j.oraloncology.2012.12.016
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2013
Authors
Publisher
Elsevier BV